Class II · Moderate riskTerminated Initiated Aug 24, 2020 (6 years ago)
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Sub-Potent Drug: Out of specification test results for potency (below specification).
What was recalled
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Recalling firm
Teva Pharmaceuticals USA
NDC code
0093-4177-73
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1566-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of…